METASTATIC TRIPLE NEGATIVE BREAST CANCER

Clinical trials for METASTATIC TRIPLE NEGATIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 4 Completed 2 Terminated 1

Trial tests new combo for Tough-to-Treat breast cancer

Disease control Terminated

This study tested whether combining two drugs, olinvacimab and pembrolizumab, could help control metastatic triple-negative breast cancer. It was for women who had already tried at least one other treatment for their advanced cancer. The goal was to see if this combination could …

Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER

Phase: PHASE2 • Sponsor: PharmAbcine • Aim: Disease control

Last updated Mar 23, 2026 15:29 UTC

METASTATIC TRIPLE NEGATIVE BREAST CANCER

Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCER trials appear

Trial tests new combo for Tough-to-Treat breast cancer